Milagros Abad-Licham
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Milagros Abad-Licham has a total of 98 co-authors. Here are the top co-authors by number of shared publications:
- Juan Carlos Astigueta
Instituto Regional de Enfermedades Neoplasicas Norte, Trujillo
11 shared publications Teresa Cusma-Quintana
3 shared publicationsDaniel Carbajal-Vásquez
2 shared publicationsEloy Silva-Capuñay
2 shared publications- Jose Galvez-Olortegui
Service of Ophthalmology, Hospital del Oriente de Asturias, Asturias, Spain
2 shared publications Juan Astigueta
Univ Privada Antenor Orrego, Fac Med, Trujillo 13008, Peru
2 shared publications
Latest Publications
- 30 April 2026
- Published by Wiley in Cytopathology
- Vol. 37 (5) , 472-484
Role of Scientific Societies in Continuing Education in Cytopathology: Present and Future Perspectives
This article analyzes the role of Scientific Medical Societies (SMS) in continuing education in Cytopathology, emphasizing their impact on professional development, diagnostic quality, and patient safety. In recent years, Cytopathology has undergone significant growth driven by technological and molecular advances, which have expanded its scope and complexity. In this context, SMS play a crucial role by offering training activities such as congresses, courses, workshops, and publications, acting as a bridge between scientific evidence and clinical practice. The article also addresses current challenges related to equitable access, pedagogical innovation, and the integration of new technologies, as well as potential strategies for strengthening continuing education and international cooperation.
- 30 April 2026
- Published by Wiley in Cytopathology
- Vol. 37 (5) , 472-484
Role of Scientific Societies in Continuing Education in Cytopathology: Present and Future Perspectives
This article analyzes the role of Scientific Medical Societies (SMS) in continuing education in Cytopathology, emphasizing their impact on professional development, diagnostic quality, and patient safety. In recent years, Cytopathology has undergone significant growth driven by technological and molecular advances, which have expanded its scope and complexity. In this context, SMS play a crucial role by offering training activities such as congresses, courses, workshops, and publications, acting as a bridge between scientific evidence and clinical practice. The article also addresses current challenges related to equitable access, pedagogical innovation, and the integration of new technologies, as well as potential strategies for strengthening continuing education and international cooperation.
- Open Access
- 2 March 2026
- Published by Cuerpo Médico del Hospital Nacional Almanzor Aguinaga Asenjo in Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo
- Vol. 19 (1) , e2925
Impronta Citológica del Ganglio Centinela Post-Neoadyuvancia en Cáncer de Mama: Evaluación Diagnóstica Intraoperatoria en Instituto Oncológico del Norte del Perú
Introducción: Evaluar la efectividad diagnóstica de la técnica del ganglio centinela con impronta en pacientes con cáncer de mama post Neoadyuvancia en el IREN durante 2019-2024. El estudio: Se realizo un estudio prueba diagnóstica retrospectivo transversal en la población norte del Perú. La variable dependiente fue parafina del ganglio centinela (GLC), mientras que la independiente fue citología post neoadyuvancia del GLC. Hallazgos: La sensibilidad, especificidad, el valor predictivo positivo (VPP) y valor predictivo negativo (VPN) del ganglio centinela con impronta fueron de 60%, 98,95%, 81,82% y 96,92% respectivamente. Además, una razón de verosimilitud positiva de 57,14 y razón de verosimilitud negativa de 0,40 Conclusiones: La citología con impronta post- neoadyuvancia es útil para confirmar, pero no descartar, malignidad, ya que tiene un cociente de verosimilitud positivo superior a 10, pero uno negativo superior a 0,1.
- 2 March 2026
- Published by Cuerpo Médico del Hospital Nacional Almanzor Aguinaga Asenjo in Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo
- Vol. 19 (1) , e2925
Open AccessImpronta Citológica del Ganglio Centinela Post-Neoadyuvancia en Cáncer de Mama: Evaluación Diagnóstica Intraoperatoria en Instituto Oncológico del Norte del Perú
Introducción: Evaluar la efectividad diagnóstica de la técnica del ganglio centinela con impronta en pacientes con cáncer de mama post Neoadyuvancia en el IREN durante 2019-2024. El estudio: Se realizo un estudio prueba diagnóstica retrospectivo transversal en la población norte del Perú. La variable dependiente fue parafina del ganglio centinela (GLC), mientras que la independiente fue citología post neoadyuvancia del GLC. Hallazgos: La sensibilidad, especificidad, el valor predictivo positivo (VPP) y valor predictivo negativo (VPN) del ganglio centinela con impronta fueron de 60%, 98,95%, 81,82% y 96,92% respectivamente. Además, una razón de verosimilitud positiva de 57,14 y razón de verosimilitud negativa de 0,40 Conclusiones: La citología con impronta post- neoadyuvancia es útil para confirmar, pero no descartar, malignidad, ya que tiene un cociente de verosimilitud positivo superior a 10, pero uno negativo superior a 0,1.
- Open Access
- 8 May 2024
- Published by Instituto Nacional de Salud (Peru) in Revista Peruana de Medicina Experimental Y Salud Pública
- Vol. 41 (1) , 62-8
Cáncer de mama en el norte del Perú: subtipos moleculares y HER2 low
El objetivo del estudio fue conocer el perfil inmunohistoquímico del cáncer de mama e identificar elsubgrupo HER2 low en la macrorregión norte del Perú. Se realizó un estudio transversal con una muestra de 1176 pacientes atendidos en el Instituto Regional de Enfermedades Neoplásicas Norte del Perú desde enero de 2016 a diciembre de 2023. Los datos recolectados (edad, tipo histológico, grado y resultados complementarios), se analizaron con frecuencias y porcentajes. El perfil correspondió a: luminal B (45,6%); luminal A (24,7%); triple negativo (18,2%); y HER2 positivo no luminal (11,5%). Además, HER2 low fueron 215 pacientes (25,1% de los considerados previamente negativos). Este estudio proporciona evidencia que la subtipificación de cáncer de mama ha cambiado, siendo luminal B más frecuente, y es esencial involucrar a políticas de salud para adquirir terapias dirigidas considerando a pacientes HER2 low.
- 8 May 2024
- Published by Instituto Nacional de Salud (Peru) in Revista Peruana de Medicina Experimental Y Salud Pública
- Vol. 41 (1) , 62-8
Open AccessCáncer de mama en el norte del Perú: subtipos moleculares y HER2 low
El objetivo del estudio fue conocer el perfil inmunohistoquímico del cáncer de mama e identificar elsubgrupo HER2 low en la macrorregión norte del Perú. Se realizó un estudio transversal con una muestra de 1176 pacientes atendidos en el Instituto Regional de Enfermedades Neoplásicas Norte del Perú desde enero de 2016 a diciembre de 2023. Los datos recolectados (edad, tipo histológico, grado y resultados complementarios), se analizaron con frecuencias y porcentajes. El perfil correspondió a: luminal B (45,6%); luminal A (24,7%); triple negativo (18,2%); y HER2 positivo no luminal (11,5%). Además, HER2 low fueron 215 pacientes (25,1% de los considerados previamente negativos). Este estudio proporciona evidencia que la subtipificación de cáncer de mama ha cambiado, siendo luminal B más frecuente, y es esencial involucrar a políticas de salud para adquirir terapias dirigidas considerando a pacientes HER2 low.
- Open Access
- 16 February 2024
- Published by Ecancer Global Foundation in ecancermedicalscience
- Vol. 18, 1671
Primary signet ring cell carcinoma of the cervix: case report and literature review
Primary signet ring cell carcinoma of the cervix: case report and literature review Milagros Abad-Licham1,2,3,a, Christian Cotrina4,b, Andric Guerrero2,c,
- 16 February 2024
- Published by Ecancer Global Foundation in ecancermedicalscience
- Vol. 18, 1671
Open AccessPrimary signet ring cell carcinoma of the cervix: case report and literature review
Primary signet ring cell carcinoma of the cervix: case report and literature review Milagros Abad-Licham1,2,3,a, Christian Cotrina4,b, Andric Guerrero2,c,
- Open Access
- 3 November 2022
- Published by Ecancer Global Foundation in ecancermedicalscience
- Vol. 16, 1462
Highlights from the 7th Oncological Pathology Conference ‘Pathological Anatomy in the context of the National Cancer Law: An overview of the Latin American experience’, 15, 22 and 23 July 2022, Trujillo, Peru
Highlights from the 7th Oncological Pathology Conference ‘Pathological Anatomy in the context of the National Cancer Law: An overview of the Latin American ex
- 3 November 2022
- Published by Ecancer Global Foundation in ecancermedicalscience
- Vol. 16, 1462
Open AccessHighlights from the 7th Oncological Pathology Conference ‘Pathological Anatomy in the context of the National Cancer Law: An overview of the Latin American experience’, 15, 22 and 23 July 2022, Trujillo, Peru
Highlights from the 7th Oncological Pathology Conference ‘Pathological Anatomy in the context of the National Cancer Law: An overview of the Latin American ex
- Open Access
- 5 January 2022
- Published by Universidad de Huánuco in REVISTA PERUANA DE CIENCIAS DE LA SALUD
- Vol. 4 (1) , 39-43
Carcinoma primario peritoneal sincrónico con tumor de músculo liso de potencial maligno incierto: reporte de caso
Primary peritoneal serous carcinoma (PSC) is a rare, aggressive, malignant neoplasm that is usually diagnosed incidentally, after having excluded an ovarian primary. Another rare entity is uterine smooth muscle tumor of uncertain malignant potential (STUMP), which is a borderline pathology between leiomyomas and leiomyosarcomas. Its synchronism has not been reported in the literature. We present the case of a 50-year-old woman with a twelve-month illness characterized by progressive abdominal distention, pain, weight loss, and edema in the lower limbs. The patient underwent surgery for a uterine tumor, to rule out sarcoma, finding, in addition to the gynecological neoplasia, solid peritoneal lesions. The histological diagnosis was STUMP synchronous with CSP. The evolution was unfavorable, dying three weeks after surgery. In the literature we don’t find cases of coexistence of these pathologies, so our finding represents a contribution in gynecological oncology.
- 5 January 2022
- Published by Universidad de Huánuco in REVISTA PERUANA DE CIENCIAS DE LA SALUD
- Vol. 4 (1) , 39-43
Open AccessCarcinoma primario peritoneal sincrónico con tumor de músculo liso de potencial maligno incierto: reporte de caso
Primary peritoneal serous carcinoma (PSC) is a rare, aggressive, malignant neoplasm that is usually diagnosed incidentally, after having excluded an ovarian primary. Another rare entity is uterine smooth muscle tumor of uncertain malignant potential (STUMP), which is a borderline pathology between leiomyomas and leiomyosarcomas. Its synchronism has not been reported in the literature. We present the case of a 50-year-old woman with a twelve-month illness characterized by progressive abdominal distention, pain, weight loss, and edema in the lower limbs. The patient underwent surgery for a uterine tumor, to rule out sarcoma, finding, in addition to the gynecological neoplasia, solid peritoneal lesions. The histological diagnosis was STUMP synchronous with CSP. The evolution was unfavorable, dying three weeks after surgery. In the literature we don’t find cases of coexistence of these pathologies, so our finding represents a contribution in gynecological oncology.
- Open Access
- 5 October 2021
- Published by Universidad de Huánuco in REVISTA PERUANA DE CIENCIAS DE LA SALUD
- Vol. 3 (4) , 278-287
Recomendaciones para el procesamiento de muestras y necropsias en anatomía patológica ante la pandemia de la COVID-19
Objective. Present a theoretical support to take into account in the safe execution of the work in the laboratory of pathological anatomy during the COVID19 pandemic. Methods. We reviewed the relevant bibliographic material published by WHO, prestigious specialized international institutions and national ones on biosafety in this pandemic. Results. This document contains the biosafety theoretical framework for the execution of the various procedures in the laboratory of pathological anatomy in Peru, in this scenario of SARS-Cov2 pandemic. Conclusions. Knowledge about the COVID-19 pandemic and its causative agent constantly surprises the scientific community, it is the reason why its updating and its dissemination must be permanent
- 5 October 2021
- Published by Universidad de Huánuco in REVISTA PERUANA DE CIENCIAS DE LA SALUD
- Vol. 3 (4) , 278-287
Open AccessRecomendaciones para el procesamiento de muestras y necropsias en anatomía patológica ante la pandemia de la COVID-19
Objective. Present a theoretical support to take into account in the safe execution of the work in the laboratory of pathological anatomy during the COVID19 pandemic. Methods. We reviewed the relevant bibliographic material published by WHO, prestigious specialized international institutions and national ones on biosafety in this pandemic. Results. This document contains the biosafety theoretical framework for the execution of the various procedures in the laboratory of pathological anatomy in Peru, in this scenario of SARS-Cov2 pandemic. Conclusions. Knowledge about the COVID-19 pandemic and its causative agent constantly surprises the scientific community, it is the reason why its updating and its dissemination must be permanent
- Open Access
- 29 September 2021
- Published by Revista Mexicana de Urologia based at Sociedad Mexicana de Urologia. Colegio de Profesionales AC. in Revista Mexicana de Urología
- Vol. 81 (4) , 1-11
Prostatectomía radical abierta y laparoscópica: comparación de resultados oncológicos y funcionales
Objective: To compare oncological and functional results of open and laparoscopic radical prostatectomy in patients with prostate cancer. Materials and methods: A retrospective cohort analytical study was carried out, where a total of 70 patients with a clinical diagnosis of localized prostate cancer were evaluated, during the period June 2010 to June 2015. The patients were grouped according to the technique used: open surgery (n = 40) and laparoscopic surgery (n = 30). Preoperative variables were analyzed (age, prostate-specific antigen, biopsy histology, functional status and comorbidities), perioperative (surgical time, intraoperative bleeding, hospital stay and complications), postoperative: oncological (stage, histological findings of the surgical specimen and TNM) and postoperative functional (urinary continence and potency or sexual performance). Results: No significant differences were found in oncological results; but if in intraoperative bleeding (1177 vs 440 cc; p <0.001), hospital stay (5.8 vs 4.6 days; p = 0.003), complications (35 vs 10%; p = 0.016) and continence (65 vs 93%; p = 0.018), in favor of the laparoscopic technique. When evaluating the surgical time, it was found that it was shorter with the open technique (242 vs 295 minutes; p <0.001). Conclusions: At 60 months of follow-up, there was no significant difference in oncological results or sexual potency between the two groups. With the laparoscopic technique, less intraoperative bleeding, fewer intraoperative and postoperative complications, shorter hospital stay and better recovery from urinary continence were found.
- 29 September 2021
- Published by Revista Mexicana de Urologia based at Sociedad Mexicana de Urologia. Colegio de Profesionales AC. in Revista Mexicana de Urología
- Vol. 81 (4) , 1-11
Open AccessProstatectomía radical abierta y laparoscópica: comparación de resultados oncológicos y funcionales
Objective: To compare oncological and functional results of open and laparoscopic radical prostatectomy in patients with prostate cancer. Materials and methods: A retrospective cohort analytical study was carried out, where a total of 70 patients with a clinical diagnosis of localized prostate cancer were evaluated, during the period June 2010 to June 2015. The patients were grouped according to the technique used: open surgery (n = 40) and laparoscopic surgery (n = 30). Preoperative variables were analyzed (age, prostate-specific antigen, biopsy histology, functional status and comorbidities), perioperative (surgical time, intraoperative bleeding, hospital stay and complications), postoperative: oncological (stage, histological findings of the surgical specimen and TNM) and postoperative functional (urinary continence and potency or sexual performance). Results: No significant differences were found in oncological results; but if in intraoperative bleeding (1177 vs 440 cc; p <0.001), hospital stay (5.8 vs 4.6 days; p = 0.003), complications (35 vs 10%; p = 0.016) and continence (65 vs 93%; p = 0.018), in favor of the laparoscopic technique. When evaluating the surgical time, it was found that it was shorter with the open technique (242 vs 295 minutes; p <0.001). Conclusions: At 60 months of follow-up, there was no significant difference in oncological results or sexual potency between the two groups. With the laparoscopic technique, less intraoperative bleeding, fewer intraoperative and postoperative complications, shorter hospital stay and better recovery from urinary continence were found.
- Open Access
- 1 January 2021
- Published by Cuerpo Médico del Hospital Nacional Almanzor Aguinaga Asenjo in Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo
- Vol. 14 (2) , 119-123
Short birth interval as a risk factor for ductal breast carcinoma in patients from northern Peru
Background: Breast cancer is the most common histological type and it is a frequent cause of death in Peruvian women. Objective: To demonstrate that birth interval is a risk factor for ductal breast carcinoma. Material and Methods: This case-control study included 304 Peruvian women with histological diagnosis of breast carcinoma. They were divided into two groups, one with ductal carcinoma and another with non-ductal carcinoma (control). Besides birth interval; parity, age at first delivery, age at last delivery, age at histological diagnosis, interval from last delivery to diagnosis and molecular subtype were also evaluated. Results: The frequency of Ductal breast cancer was 78% in patients with short birth interval. The ratio between presence of short birth interval versus absence of short birth interval is 1.86 times higher in ductal breast cancer patients (CI 95%: 1,12-3,08). Additionally, there was significant association in age at first delivery <= 20 years (p10 years (p<0,001). Conclusion: short birth interval is a risk factor for ductal breast cancer, which can also be modified and used as a prevention element, so it should be included in the medical record.
- 1 January 2021
- Published by Cuerpo Médico del Hospital Nacional Almanzor Aguinaga Asenjo in Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo
- Vol. 14 (2) , 119-123
Open AccessShort birth interval as a risk factor for ductal breast carcinoma in patients from northern Peru
Background: Breast cancer is the most common histological type and it is a frequent cause of death in Peruvian women. Objective: To demonstrate that birth interval is a risk factor for ductal breast carcinoma. Material and Methods: This case-control study included 304 Peruvian women with histological diagnosis of breast carcinoma. They were divided into two groups, one with ductal carcinoma and another with non-ductal carcinoma (control). Besides birth interval; parity, age at first delivery, age at last delivery, age at histological diagnosis, interval from last delivery to diagnosis and molecular subtype were also evaluated. Results: The frequency of Ductal breast cancer was 78% in patients with short birth interval. The ratio between presence of short birth interval versus absence of short birth interval is 1.86 times higher in ductal breast cancer patients (CI 95%: 1,12-3,08). Additionally, there was significant association in age at first delivery <= 20 years (p10 years (p<0,001). Conclusion: short birth interval is a risk factor for ductal breast cancer, which can also be modified and used as a prevention element, so it should be included in the medical record.
- Open Access
- 7 December 2020
- Published by Ecancer Global Foundation in ecancermedicalscience
- Vol. 14
Interventional cytopathology and cancer in Peru: how to act during COVID-19?
Interventional cytopathology and cancer in Peru: how to act during COVID-19? Milagros Abad-Licham1,2,3a, Juan Astigueta1,4b, Caddie Laberiano Ferná
- 7 December 2020
- Published by Ecancer Global Foundation in ecancermedicalscience
- Vol. 14
Open AccessInterventional cytopathology and cancer in Peru: how to act during COVID-19?
Interventional cytopathology and cancer in Peru: how to act during COVID-19? Milagros Abad-Licham1,2,3a, Juan Astigueta1,4b, Caddie Laberiano Ferná